SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77017.79
251.61 (-0.33%)

Filter

Top Pharma Companies in India as on May-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Jubilant Pharmova Ltd.	Q V+ PT	14,820 Small Cap	938.50 (0.87%)	N/A	6.58	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Suven Life Sciences Ltd.	Q V+ PT	5,611 Small Cap	205.65 (-3.34%)	N/A	5.3	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Aster DM Healthcare Ltd.	Q V+ PT	38,584 Small Cap	742.85 (-0.25%)	99.41	8.43	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Panacea Biotec Ltd.	Q V+ PT	2,280 Small Cap	370.15 (-0.55%)	N/A	8.02	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Sanofi India Ltd.	Q V PT	7,831 Small Cap	3,402.85 (0.07%)	25.28	10.04	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Nectar Lifesciences Ltd.	Q V+ PT	237 Small Cap	12.28 (0.74%)	N/A	0.3	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Novartis India Ltd.	Q V+ PT	2,523 Small Cap	1,038.10 (1.59%)	25.95	3.19	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Aurobindo Pharma Ltd.	Q V+ PT	79,907 Mid Cap	1,428.20 (3.81%)	37.5	3.63	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,11,261 Large Cap	7,771.20 (0.43%)	77.07	11.47	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	4,537 Small Cap	140.05 (0.18%)	N/A	-10.57	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Solara Active Pharma Sciences Ltd.	Q V PT	2,497 Small Cap	501.80 (-3.20%)	N/A	2.01	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Laxmi Dental Ltd.	Q V PT	1,153 Small Cap	205.10 (-2.26%)	89.39	4.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	2,787 Small Cap	94.66 (-0.29%)	24.04	1.57	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	CORONA Remedies Ltd.	Q V+ PT	10,588 Small Cap	1,752.55 (1.23%)	71.04	15.12	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Park Medi World Ltd.	Q V+ PT	10,375 Small Cap	239.25 (-0.40%)	1445.18	75.04	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Krsnaa Diagnostics Ltd.	Q V PT	1,914 Small Cap	588.70 (-0.24%)	23.81	2.04	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Senores Pharmaceuticals Ltd.	Q V+ PT	4,111 Small Cap	881.60 (-1.24%)	298.11	5.74	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Onesource Specialty Pharma Ltd.	Q V PT	20,133 Small Cap	1,748.25 (-0.45%)	115.3	3.4	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Aarti Pharmalabs Ltd.	Q V+ PT	7,304 Small Cap	771.90 (-4.20%)	34	3.75	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Piramal Pharma Ltd.	Q V PT	21,308 Small Cap	159.80 (-0.31%)	30.44	2.62	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Nephrocare Health Services Ltd.	Q V+ PT	5,493 Small Cap	536.80 (-1.94%)	160.43	9.94	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Gujarat Kidney And Super Speciality Ltd.	Q V+ PT	992 Small Cap	121.60 (-3.34%)	682.34	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Blue Jet Healthcare Ltd.	Q V PT	8,263 Small Cap	490.70 (3.01%)	28.15	6.38	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Fabtech Technologies Ltd.	Q V PT	736 Small Cap	165.15 (-0.21%)	30.33	1.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,910 Small Cap	4,592.60 (-3.05%)	42.3	24.15	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Wockhardt Ltd.	Q V+ PT	23,163 Small Cap	1,537.25 (7.84%)	108.75	5	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Pfizer Ltd.	Q V PT	21,427 Small Cap	4,698.80 (0.32%)	25.1	5.37	1.18	5.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Biocon Ltd.	Q V PT	58,418 Mid Cap	368.90 (2.36%)	7894.26	3.64	2.44	-9.71	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Glaxosmithkline Pharmaceuticals Ltd.	Q V+ PT	39,829 Mid Cap	2,362.25 (0.47%)	39.01	19.88	3.06	33.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Hikal Ltd.	Q V+ PT	2,400 Small Cap	196.55 (0.98%)	N/A	2.02	4.29	-1.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Wockhardt	1,537.25	7.84%
Anuh Pharma	85.43	7.19%
Lincoln Pharma	682.10	6.37%
Poly Medicure	1,600.15	4.99%
Aurobindo Pharma	1,428.20	3.81%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Syngene Internation.	451.55	-5.43%
Emcure Pharma	1,691.45	-5.25%
RPG Life Sciences	2,320.50	-4.26%
Aarti Pharmalabs	771.90	-4.20%
Tarsons Products	214.75	-3.94%

News about Top Pharma Companies in India

May, 2026

Sanofi Consumer Healthcare India informs about disclosures

Sanofi Consumer Healthcare India has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon India Mutual Fund.

The above information is a part of company’s filings submitted to BSE.

May, 2026

Wockhardt - Quaterly Results

A decent increase of about 45.35% in the sales to Rs. 5160.00 millions was observed for the quarter ended March 2026. The sales figure stood at Rs. 3550.00 millions during the year-ago period.Net Profit for the quarter ended March 2026 zoomed to 317.50% from Rs. 400.00 millions to Rs. 1670.00 millions.The company reported a good operating profit of 2160.00 millions compared to 1200.00 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	5160.00	3550.00	45.35	17390.00	14020.00	24.04	17390.00	14020.00	24.04
Other Income	550.00	140.00	292.86	1370.00	550.00	149.09	1370.00	550.00	149.09
PBIDT	2160.00	1200.00	80.00	6540.00	3550.00	84.23	6540.00	3550.00	84.23
Interest	410.00	400.00	2.50	1760.00	1990.00	-11.56	1760.00	1990.00	-11.56
PBDT	2100.00	800.00	162.50	5030.00	1560.00	222.44	5030.00	1560.00	222.44
Depreciation	430.00	400.00	7.50	1860.00	1680.00	10.71	1860.00	1680.00	10.71
PBT	1670.00	400.00	317.50	3170.00	-120.00	-2741.67	3170.00	-120.00	-2741.67
TAX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	1670.00	400.00	317.50	3170.00	-120.00	-2741.67	3170.00	-120.00	-2741.67
Equity	810.00	810.00	0.00	810.00	810.00	0.00	810.00	810.00	0.00
PBIDTM(%)	41.86	33.80	23.84	37.61	25.32	48.52	37.61	25.32	48.52

May, 2026

Wockhardt informs about press release

Pursuant to Regulation 30 of the Listing Regulations, Wockhardt has enclosed Press Release on the Audited Financial Results (Standalone and Consolidated) for the quarter and the financial year ended 31st March, 2026. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com

The above information is a part of company’s filings submitted to BSE.

May, 2026

OneSource Specialty Pharma informs about press release

OneSource Specialty Pharma has informed that it enclosed Press Release issued by the Company titled: OneSource Supports Second Generic Semaglutide Approval in Canada Enables commercialisation for the first two entrants in the world’s second-largest semaglutide market.

The above information is a part of company’s filings submitted to BSE.

May, 2026

OneSource Specialty’s partner gets Health Canada nod for generic version of Ozempic

This marks the second generic semaglutide approval in Canada

May, 2026

Aster DM Healthcare informs about earnings call

Aster DM Healthcare has informed that the Earnings Call of the Company for the quarter and year ended March 31, 2026, was held on May 01, 2026, and the Video/Audio Recording with respect to Earnings Call is available on the website of the Company at https://www.asterdmhealthcare.in/investors/financial-information/audio-video-recordings-earningsquarterly-calls.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Jubilant Pharmova Ltd.	14,820 Crore
2	Suven Life Sciences Ltd.	5,611 Crore
3	Aster DM Healthcare Ltd.	38,584 Crore
4	Panacea Biotec Ltd.	2,280 Crore
5	Sanofi India Ltd.	7,831 Crore
6	Nectar Lifesciences Ltd.	237 Crore
7	Novartis India Ltd.	2,523 Crore
8	Aurobindo Pharma Ltd.	79,907 Crore
9	Apollo Hospitals Enterprise Ltd.	1,11,261 Crore
10	Sun Pharma Advanced Research Company Ltd.	4,537 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,324	54,030	35.45	12.32	24.78	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,276	1,43,909	63.34	15.84	35.80	26.68
Ajanta Pharma Ltd. (S)	Very Good	2,901	36,283	35.76	7.91	24.47	24.45
Lupin Ltd. (M)	Somewhat Good	2,343	1,07,489	23.14	5.16	13.79	20.83
Zydus Lifesciences Ltd. (M)	Very Good	912	90,727	18.37	3.45	11.47	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,164	62,974	88.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,420	67,519	73.93
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,096	33,373	31.79
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,276	1,43,909	30.58
Gland Pharma Ltd. (S)	Very Good	1,773	29,941	29.37
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,096	33,373	45.88	8.55	28.97	17.81
Mankind Pharma Ltd. (M)	Very Good	2,321	93,324	54.78	5.85	32.99	14.65
Laurus Labs Ltd. (M)	Very Good	1,164	62,974	70.85	11.88	35.61	14.42
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,271	1,07,500	19.31	2.89	11.61	13.26
Ajanta Pharma Ltd. (S)	Very Good	2,901	36,283	35.76	7.91	24.47	12.43

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	912	90,727	18.37	3.45	11.47	30.57
Cipla Ltd. (L)	Very Good	1,334	1,07,827	23.72	3.21	14.30	30.14
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,821	4,37,663	40.10	5.39	21.92	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,271	1,07,500	19.31	2.89	11.61	22.29
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,096	33,373	45.88	8.55	28.97	19.45

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Sanofi Consumer Healthcare India informs about disclosures

Wockhardt - Quaterly Results

Wockhardt informs about press release

OneSource Specialty Pharma informs about press release

OneSource Specialty’s partner gets Health Canada nod for generic version of Ozempic

Aster DM Healthcare informs about earnings call

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.